Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Russo, Francesca ^a   Bearz, Alessandra ^b   Pampaloni, Gianni ^a   Tirelli, Umberto ^b   Bordonaro, Roberto ^c   Verusio, Claudio ^d   Bian, Alberto Rosa ^e   Marangolo, Maurizio ^f   Bianco, Angelo Raffaele ^g   Grossi, Francesco ^h   Gambi, Angelo ⁱ   Francini, Guido ^j   Sogno, Giorgio ^k   Manente, Paolo ^l   Gebbia, Nicola ^m   Artioli, Fabrizio ⁿ   Ardizzoni, Andrea ^o   Masotti, Alessandro ^p   Pozzi, Ernesto ^q   Tumolo, Salvatore ^r   Passalacqua, Rodolfo ^s   Casartelli, Clelia ^t   Montanari, Franco ^u   Colucci, Giuseppe ^v   Barbera, Santi ^w   Ricci, Sergio ^x   Trodella, Lucio ^y   Valentini, Vincenzo ^y   Mantovani, Giovanni ^z   Ravaioli, Alberto ^aa   Monfardini, Silvio ^ab   Barni, Sandro ^ac   Felletti, Raffaella ^ad   Testora, Franco ^ae   Aglietta, Massimo ^af   Ardizzoia, Antonio ^ag   Bollina, Roberto ^ah   Cruciani, Giorgio ^ai   Pasquini, Enzo ^aj   more..

^a Eli Lilly Italia SpA   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d OSPEDALE DI CIRCOLO   (Italy)

^e Unità Operativa di Oncologia Medica   (Italy)

^f SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h SC Oncologia Medica A   (Italy)

ⁱ OSPEDALE DEGLI INFERMI   (Italy)

^j UNIVERSITY OF SIENA   (Italy)

^k San Paolo Hospital   (Italy)

^l UO di Oncologia Medica   (Italy)

^m UNIVERSITY OF PALERMO   (Italy)

ⁿ Unità Operativa di Medicina Oncologica   (Italy)

^o UNIVERSITY HOSPITAL OF PARMA   (Italy)

^p MAGGIORE HOSPITAL   (Italy)

^q FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^r S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^s Breast Unit Azienda Osp Istituti   (Italy)

^t VALDUCE HOSPITAL   (Italy)

^u DESIO HOSPITAL   (Italy)

^v NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^w Azienda Ospedaliera di Cosenza   (Italy)

^x UNIVERSITY OF PISA   (Italy)

^y FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^z Policlinico Universitario di Monserrato   (Italy)

^aa Ospedale Civile Infermi   (Italy)

^ab UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^ac Dipartimento Oncologia Medica   (Italy)

^ad UNIVERSITY OF GENOA   (Italy)

^ae Ospedale Civile di Asti   (Italy)

^af CANDIOLO CANCER INSTITUTE   (Italy)

^ag SAN GERARDO HOSPITAL   (Italy)

^ah San Giuseppe Hospital   (Italy)

^ai Ospedale di Lugo   (Italy)

^aj Osp Cervesi Cattolica   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; DEXAMETHASONE; FOLIC ACID; PEMETREXED; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DRUG DERIVATIVE; GLUTAMIC ACID DERIVATIVE; GUANINE;

ACUTE HEART INFARCTION; ADULT; ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ARTICLE; ASTHENIA; BLOOD DISEASE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COUGHING; DIARRHEA; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; INJECTION SITE REACTION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MELENA; METASTASIS; MONOTHERAPY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PERIPHERAL EDEMA; RISK REDUCTION; STOMATITIS; SURVIVAL TIME; THORAX PAIN; THROMBOCYTOPENIA; VOMITING; LUNG TUMOR; METABOLISM; MIDDLE AGED; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DEXAMETHASONE; FEMALE; FOLIC ACID; GLUTAMATES; GUANINE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; VITAMIN B 12;

EID: 51349157516     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-216     Document Type: Article

References (20)

1. Parkin DM Bray F Ferlay J Pisani P Global cancer statistics, 2002 CA Cancer J Clin 2005, 55(2):74-108 15761078
2. Ho C Davies AM Lara PN Jr Gandara DR Second-line treatment for advanced-stage non-small-cell lung cancer: Current and future options Clin Lung Cancer 2006, 7(Suppl 4):S118-25 16764752
3. Wakelee H Belani CP Optimizing first-line treatment options for patients with advanced NSCLC Oncologist 2005, 10(Suppl 3):1-10 10.1634/ theoncologist.10-90003-1 16368866
4. Walling J Chemotherapy for advanced non-small-cell lung cancer Resp Med 1994, 88:649-657 10.1016/S0954-6111(05)80061-7 7528933
5. Molina JR Adjei AA Jett JR Advances in chemotherapy of non-small cell lung cancer Chest 2006, 130(4):1211-9 10.1378/chest.130.4.1211 17035458
6. Blackhall FH Shepherd FA Albain KS Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer: A realistic goal? Treat Respir Med 2005, 4(2):71-84 10.2165/ 00151829-200504020-00001 15813659
7. Sorenson S Glimelius B Nygren P A systematic overview of chemotherapy effects in non-small cell lung cancer Acta Oncol 2001, 40(2-3):327-39 10.1080/02841860151116402 11441939
8. Shih C Chen VJ Gossett LS Gates SB MacKellar WC Habeck LL Shackelford KA Mendelsohn LG Soose DJ Patel VF Andis SL Bewley JR Rayl EA Moroson BA Beardsley GP Kohler W Ratnam M Schultz RM LY23 a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes Cancer Res 1514, 57(6):1116-1123
9. Schilsky RL Antimetabolites The Chemotherapy Source Book Baltimore (MD): Williams & Wilkins Perry MC 1992:301-315
10. Solomon B Bunn PA Jr Clinical activity of pemetrexed: A multitargeted antifolate anticancer agent Future Oncol 2005, 1(6):733-46 10.2217/ 14796694.1.6.733 16556051
11. Hanauske AR Dittrich C Otero J Overview of phase I/II pemetrexed studies Oncology (Williston Park) 2004, 18(13 Suppl 8):18-25 15655932
12. Scagliotti GV Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer Semin Oncol 2005, 32(2 Suppl 2):S5-8 10.1053/ j.seminoncol.2005.02.006 15818537
13. Manegold C Pemetrexed: Its promise in treating non-small-cell lung cancer Oncology (Williston Park) 2004, 18(8 Suppl 5):43-8 15339059
14. Hanna N Shepherd FA Fossella FV Pereira JR De Marinis F von Pawel J Gatzemeier U Tsao TC Pless M Muller T Lim HL Desch C Szondy K Gervais R Shaharyar Manegold C Paul S Paoletti P Einhorn L Bunn PA Jr Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy J Clin Oncol 2004, 22(9):1589-97 10.1200/JCO.2004.08.163 15117980
15. Cancer Therapy Evaluation Program Common Toxicity Criteria, Version 2.0. DCTD, NCI, NIH, DHHS 1998.
16. Therasse P Arbuck SG Eisenhauer EA Wanders J Kaplan RS Rubinstein L Verweij J Van Glabbeke M Van Oosterom AT Christian MC Gwyther SG New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 2000, 92(3):205-16 10.1093/jnci/92.3.205 10655437
17. Smit EF Mattson K von Pawel J Manegold C Clarke S Postmus PE ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: A phase II study Ann Oncol 2003, 14(3):455-60 10.1093/annonc/ mdg099 12598353
18. Scagliotti GV Shin DM Kindler HL Vasconcelles MJ Keppler U Manegold C Burris H Gatzemeier U Blatter J Symanowski JT Rusthoven JJ Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma J Clin Oncol 2003. 21(8):1556-61 10.1200/JCO.2003.06.122 12697881
19. Ramalingam S Sandler AB Salvage therapy for advanced non-small cell lung cancer: Factors influencing treatment selection Oncologist 2006, 11(6):655-65 10.1634/theoncologist.11-6-655 16794244
20. Monnerat C Le Chevalier T Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer Ann Oncol 2006, 17(Suppl 5):86-90 10.1093/annonc/mdj958 16807472